Page 56 - Tata_Chemicals_yearly-reports-2019-20
P. 56

Nurturing food technology for healthy living

                                             Global markets are witnessing a growing base of
                                             discerning and lifestyle-conscious consumers who are
                                             increasingly demanding food and supplements that
                                             balance functionalities (naturalness, safety and nutrition)
                                             and positive eating experience. We are striving to deliver
                    Nutritional              on this with our rich knowledge in fermentation, food
                     Sciences                technology and biogenomics.




           Competitive advantage             Business overview               We are among the few prebiotics
         1         Expertise                 backed ingredient and formulation   cell fermentation route, using in-house
                                                                             manufacturers following the whole-
                                             We offer nature-inspired and science-
                                                                             developed patented technology. Our
                      In human nutrition and
                                             solutions, marketed under the brand Tata
                                                                             operation is supported by a multi-
                     microbiome
                                             NQ, catering to human and animal health.
                      In fermentation technology
                                                                             on microbiome science (the core science
                                             and GOSSENCE® – are prebiotic dietary
                     that enables production   Our flagship product lines – FOSSENCE®   disciplinary team of scientists working
                     using whole cell route,   fibres that promote gut microbiome   platform) and fermentation technology (the
                     opening opportunities   growth for better digestive and   manufacturing platform) as well as state-
                     in other human nutrition   immune health.               of-the-art manufacturing facilities. We hold
                     segments, using the                                     numerous publications and patents.
                     biosynthesis route
          2        Strong partnerships       Product portfolio

                   With Indian and global
                   academic institutions and
                   research bodies to further gut
                   microbiota knowledge and the   Fructo oligosaccharide (FOS)  Glacto oligosaccharide (GOS)
                   effects of its modulation on   Segment                      Segment
                   human health.             Prebiotics                        Prebiotics
          3        Leading efforts           Customers                         Customers

                                             B2B: Wellness food and beverage
                                                                               B2B: Infant and dairy food
                                             (F&B), nutraceutical formulations,
                                                                               companies
                   In Bio-informatics usage
                   in human gut microbiota
                                             and animal feed companies
                   with development of
                   accurate predictive models
                   of microbiome response to
                   interventions.
          4        Robust application
                   support
                   Enabling close co-ordination
                   with customers on new
                   product development
                   (NPD) projects and deep
                   understanding of their
                   requirements.


           54  I  INTEGRATED ANNUAL REPORT 2019-20
   51   52   53   54   55   56   57   58   59   60   61